http://www.geneflux.net.

my



(ISO9001:2008 Certified Company)
(ISO17025:2005 Accreditated
(ISO13485:2003 Certified laboratory facility)
Frost & Sullivan Award -2010, for the Niche company in
Molecular Diagnostics in Asia Pacific Region

Frost & Sullivan Award -2012, for the Southeast Asia
Fastest Growing Company in Molecular Diagnostics
for Infectious Disease
10/1/2014 1
Geneflux - background
Geneflux Biosciences Sdn. Bhd. is a privately held,
research and technology driven biotechnology and
molecular diagnostics company specialized in the
manufacture of molecular diagnostic kits and providing
services to healthcare industry.
Establishment: in the year 2007 in Malaysia and India
BioNexus Status Company Award: June 2008
Geneflux Diagnostics Sdn. Bhd. is a wholly owned
subsidiary of Geneflux Biosciences, dedicated to provide
molecular diagnostic services in Malaysia.
Establishment: in the year 2009 in Malaysia
10/1/2014 2
Management
Board of Directors
Ir.Balaguru Naidu, Director & CEO
Dr.Prashanth G.Bagali, Director & COO, SVP
Mr. Azlan bin Baharom, Director
Mr. Mohammad Abdul Samad, Director

Business & Organizational Leaders
Ir.Balaguru Naidu, CEO
Dr.Prashanth G.Bagali, COO & SVP-Sci. and Tech.


10/1/2014 3
Company data
Authorized capital: RM500,000.00
Issued capital: RM425,000.00
Company #: 769382-V; Registration: April 13, 2007
Registered address: 7-3 block ), Jalan Selingsing 3, Taman
Sri Kuching, 51200, Kuala Lumpur, Malaysia
Business address: G1&G2, Menara KLH, Bandar Puchong
Jaya, 47100 Puchong, Selangor DE, Malaysia
Telephone; +60-3-80701154; Fax: +60-3-80703654
Email: info@geneflux.net.my, pgbagali@geneflux.net.my
10/1/2014 4
Certification & registrations
BioNexus Status Company Award: June 2008
Certification under Malaysian Biotechnology Corporation
Achievement under Technofund scheme Ministry of Science, Technology and
Innovation (MOSTI) project grant and Award
Frost & Sullivan Award -2010, for the Niche company in Molecular Diagnostics
in Asia Pacific Region
Frost & Sullivan Award -2012, for the Southeast Asia Fastest Growing
Company in Molecular Diagnostics for Infectious Disease
Certification of ISO9001:2008
Certification of ISO13485:2003
Accreditation of ISO17025:2005
RCPA Quality Assurance Program, Australia
Institute of Medical Research (IMR) Internal Quality Assessment Scheme,
Malaysia
Registrations: MOF, MITI, MATRDE
10/1/2014 5
Global Presence
*Geneflux Biosciences Private Limited, Bangalore
*Geneflux Diagnostics Limited, London
*Geneflux Biodiagnostics LLC, Detroit (USA)

Total Staff: 19
Science & Technology division: 8
Admin, HR & Support Division: 5
Sales, Marketing and Customer Support: 2
Logistics and Operations Division: 4

* = independent companies






10/1/2014 6
Science & Technology team
Prashanth Bagali, PhD (Genetics), PhD (Biotech),PDF (NIH-
NIDDK, USA)
Geetha Subramaniam, PhD (Med.Microbiology)
Parimala, BS (Biomedicine)
Pathma, BS (Biomedicine)
Ketan Kumar, BE (biotechnology)
Erwina [B.S (1
st
year ) in Biotechnology]
Nurfasha [B.S (1
st
year) in Biotechnology]
Lab. Assistants
Lab. Technicians



10/1/2014 7
SCIENCE & TECHNOLOGY
Molecular Diagnostics Services Research
Viruses
Bacteria
Technologies
PCR Technology
2D & 3D Gels
analysis
Protein
Profiling
Contract
Research
Product
Development
Training
PRODUCTS AND SERVICES
Product
validation
Microarray
Projects
10/1/2014 8
Core Technologies
Nucleic acid (DNA and RNA) based tests
Polymerase chain reaction (PCR)
Real time reverse transcriptase PCR (RT-PCR)

Microbiology lab tests
ELISA based tests
Rapid Antigen Tests
10/1/2014 9
Core Business
1. Manufacturing of molecular diagnostic kits
2. Providing diagnostic services to private and public
hospitals, clinics and medical centres

Geneflux Diagnostics Sdn. Bhd. is the wholly owned
subsidiary of Geneflux Biosciences Sdn Bhd.
Directors / shareholders:
1. Ir.Balaguru Naidu
2. Dr.Prashanth G.Bagali


10/1/2014 10
Diagnostics Laboratory
ISO9001:2008 certified quality management system
ISO17025:2005 (accreditation for laboratory quality and proficiency )
ISO13485:2003 design, manufacturing and production of molecular
diagnostic test kits and providing diagnostic services

4000 sq.ft built-in area
Very well equipped to handle 1000 samples for PCR analysis everyday
Statutory and regulatory compliance to Biosafety and clinical waste
disposal
Work bench capacity: simultaneously 14 persons can work
Total investment: 2.5 million ringgits (approx. US$750,000)
10/1/2014 11
Diagnostics Laboratory (contd)
Highlights
1. Five room concept:
Sample processing room
Pre-PCR room
Post-PCR room
Lab bench room
Decontamination / instrument room: Ice maker, freezers,
MilliQ water purification system, incubators, wash area
10/1/2014 12
Diagnostics Laboratory (contd)
Molecular biology equipments
1. PCR machines (Biorad, Eppendorf, Qiagen) : 2 conventional
PCR, 3 real time PCR
2. Class II biological safety cabinets: 2
3. Freezers / fridges (Sanyo, Toshiba, Hitachi, Haier): 5
4. MilliQ water purification system
5. Gel documentation (Alpha Imager): 1
6. Centrifuges minicentrifuges, high speed: 4
7. Concentrator, autoclave, Ice maker and incubators
8. Others: Thermomixer, electrophoresis units, PCR
workstations, ductless fume cabinet


10/1/2014 13
Collaborations - R & D
Research collaborators:
1. University of Malaya (UM)
2. Universiti Putra Malaysia (UPM)
3. Universiti Kebangsaan Malaysia (UKM)
4. University Technology Petronas (UTP)
5. Universiti Sains Malaysia (USM)
6. Malaysian Palm Oil Board (MPOB)

Patents / Innovation / Licenses:
4 Licenses




10/1/2014 14
Market Need and demand

10/1/2014 15
Business strategy
1. Franchising
2. Scaling up of business operation
3. Acquisition
4. Strategic Alliance
10/1/2014 16
Investment for business expansion
1. Pathology Services
(a) PCR tests: New tests will be included to the existing list of PCR
tests
(b) Genetic tests: Existing list of tests. Dedicated team of Sales
executives for building awareness in other states outside KL and
Selangor.
(c) Microarray and Next generation based sequencing based
diagnostic tests
(d) Business relationship with IMR, HKL, Sungai Buloh Hospital and
National Public Health to increase inflow of samples with a "unique
profit sharing strategy".
10/1/2014 17
Investment for business expansion (contd.)
2. Clinical Research Services
(a) CRO (Contract Research Outsourcing) to biotech and
pharmaceutical companies
(b) Analytical services customized to specific requirement

10/1/2014 18
Investment for business expansion (contd.)
(3) Wellness Centre- based on the concept of predictive, preventive
and personalized medicine.
(a) Individual offerings: Examples are Age wise tests for wellness,
Gender based test package, Smoker panels, Drug and alcohol rehab
tests,
(b) Corporate Offerings: Pre-employment packages, Annual health
checkups
(c) Occupational Health offerings

10/1/2014 19
Investment for business expansion (contd.)
(4) Centre of Excellence (CoE) will participate in national and
international quality assurance programs and schemes; to become
National Reference Laboratory
(a) CoE for Microbiology
(b) CoE for Molecular Pathology
(c) CoE for Cancer in collaboration with Merck or Roche or
AstraZenaca or Sanofi Pharma to popularize Companion Diagnostics
10/1/2014 20
Investment for business expansion (contd.)
(5) Research and Development
(a) Medical Biotechnology with specific focus on diabetes, cancer, CVD
and others
(b) Agricultural Biotechnology with specific focus on medicinal plants

(6) Dental pulp stem cell banking:
10/1/2014 21
Products & Services
Geneflux conventional PCR and RT-PCR based kits
1. MyDENKit, detection and serotyping of dengue
virus using SybrGreen probe based real time PCR
2. Chikungunya detection kit (lab use only) using
conventional PCR
3. MuRSAFlux , identification of Methicillin
resistance staphylococcus aureus (lab use only)
4. FluFinder-detection of H1N1 virus (lab use only)

10/1/2014 22

10/1/2014 23
There is great market need and demand for PCR tests and
opportunity in both public and private sectors. Geneflux
has the technological expertise and right team to provide
solution within the best TAT (turn around time) and at
affordable price.

There is money to be made!!!!

10/1/2014 24
At your service
Thank You
10/1/2014 25
1. Sample Receiving ROOM


2.Pre-PCR room


3.Post PCR room